Hepatitis B reactivation in psoriasis patients treated with anti-TNF agents: prevention and management

The risk of hepatitis B virus (HBV) reactivation (HBVr) in chronic HBV carriers, in occult HBV patients or in acute HBV patients affected by psoriasis and treated with anti-tumor necrosis factor (TNF)-α agents is a clinical practice issue to face with, particularly if the treatment has a long-term m...

Descripción completa

Detalles Bibliográficos
Autores principales: Cannizzaro, Maria Vittoria, Franceschini, Chiara, Esposito, Maria, Bianchi, Luca, Giunta, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774605/
https://www.ncbi.nlm.nih.gov/pubmed/29387606
http://dx.doi.org/10.2147/PTT.S108209

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774605/
https://www.ncbi.nlm.nih.gov/pubmed/29387606
http://dx.doi.org/10.2147/PTT.S108209

Ejemplares similares